approval
savePOLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 5
- approvaltrastuzumab emtansine: KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalSep 27, 2020
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalSep 30, 2020
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalAug 7, 2020
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalJul 30, 2020
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalNov 10, 2020
comments(0)
5-min edit window · permanent after that